FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to medicine and deals with composition for delivering nucleic acids into cells of mammals in presence and absence of serum in growth medium. Composition includes polycationic amphiphile and neutral phospholipid, and forms complex with nucleic acid.
EFFECT: invention ensures high efficiency and low toxicity of composition and ability to deliver to cells of mammals both short and extended nucleic acids.
1 cl, 4 ex, 2 dwg, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| CARBOHYDRATE-CONTAINING CATIONIC AMPHIPHILES, CAPABLE OF DELIVERING NUCLEIC ACID IN MAMMAL CELLS | 2009 |
|
RU2394834C1 |
| COMPOSITION CONTAINING DISULPHIDE POLYCATIONIC AMPHIPHILE WITH NEUTRAL PHOSPHOLIPIDE AND METHOD FOR PRODUCING THEREOF | 2016 |
|
RU2610271C1 |
| POLYETHYLENE GLYCOL-CONTAINING LIPID, COMPOSITION BASIS THEREOF WITH CATIONIC AMPHIPHILIC AND NEUTRAL PHOSPHOLIPID AND METHOD FOR PREPARATION THEREOF FOR DELIVERING NUCLEIC ACIDS IN VIVO | 2017 |
|
RU2683572C1 |
| UNCHARGED LIPID, COMPOSITION BASED ON IT WITH POLYCATIONIC AMPHIPHILIC MOLECULE, AND NEUTRAL PHOSPHOLIPID, AND METHOD FOR ITS PREPARATION FOR DELIVERY OF NUCLEIC ACIDS IN VITRO | 2020 |
|
RU2747559C1 |
| rac- N-[2,3-DI(TETRADECYLOXY)PROP-1-YL]PYRIDINIUM BROMIDE AS AGENT FOR DELIVERING NUCLEIC ACIDS INTO MAMMAL CELLS | 2009 |
|
RU2405772C1 |
| METHOD OF PRODUCING AN OLIGONUCLEOTIDE COMPLEX FOR MAMMALIAN CELL DELIVERY | 2018 |
|
RU2698726C1 |
| COMPOSITION FOR INHIBITING GROWTH AND STIMULATION OF APOPTOSIS OF COLORECTAL CANCER CELLS | 2016 |
|
RU2644675C1 |
| BIODEGRADABLE CATIONIC POLYMERS | 2005 |
|
RU2440380C2 |
| DELIVERY OF NUCLEIC ACIDS | 1995 |
|
RU2160278C2 |
| 1-HEXADECYL-5-(1-PYRENEBUTYL)-N-(L-ORNITILE)-L-GLUTAMATE BISCHLORIDE | 2009 |
|
RU2409587C2 |
